Document is current
Any future updates will be listed below
-
Authors
Wigger, Leonore https://orcid.org/0000-0001-5230-0265
Barovic, Marko https://orcid.org/0000-0002-0839-6009
Brunner, Andreas-David
Marzetta, Flavia
Schöniger, Eyke
Mehl, Florence https://orcid.org/0000-0002-9619-1707
Kipke, Nicole
Friedland, Daniela
Burdet, Frederic
Kessler, Camille
Lesche, Mathias https://orcid.org/0000-0002-3274-7163
Thorens, Bernard https://orcid.org/0000-0002-3738-0129
Bonifacio, Ezio
Legido-Quigley, Cristina
Barbier Saint Hilaire, Pierre
Delerive, Philippe
Dahl, Andreas https://orcid.org/0000-0002-2668-8371
Klose, Christian
Gerl, Mathias J. https://orcid.org/0000-0002-8074-7221
Simons, Kai
Aust, Daniela
Weitz, Jürgen
Distler, Marius
Schulte, Anke M.
Mann, Matthias https://orcid.org/0000-0003-1292-4799
Ibberson, Mark https://orcid.org/0000-0003-3152-5670
Solimena, Michele https://orcid.org/0000-0002-3653-8107
- License Information
-
More Information
Article History
Received: 4 December 2020
Accepted: 21 May 2021
First Online: 28 June 2021
Competing interests
: K. S. is CEO of Lipotype. K. S. and C. K. are shareholders of Lipotype. M. J. G. is an employee of Lipotype. P. B. S. H. and P. D. are employees of Servier. A. S. is an employee of Sanofi-Aventis Deutschland. The other authors declare no conflict of interest.
